LNA Santé S.A.
LNA.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €807 | €736 | €728 | €689 |
| % Growth | 9.6% | 1.1% | 5.6% | – |
| Cost of Goods Sold | €716 | €495 | €106 | €112 |
| Gross Profit | €91 | €241 | €622 | €578 |
| % Margin | 11.3% | 32.8% | 85.5% | 83.8% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €98 | €90 | €87 | €82 |
| SG&A Expenses | €1 | €90 | €87 | €82 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €193 | €88 | €472 | €437 |
| Operating Expenses | €193 | €178 | €559 | €519 |
| Operating Income | €69 | €63 | €64 | €56 |
| % Margin | 8.6% | 8.6% | 8.8% | 8.1% |
| Other Income/Exp. Net | €0 | -€26 | -€20 | -€17 |
| Pre-Tax Income | €34 | €37 | €44 | €39 |
| Tax Expense | €11 | €13 | €16 | €15 |
| Net Income | €22 | €23 | €26 | €24 |
| % Margin | 2.7% | 3.2% | 3.5% | 3.4% |
| EPS | 2.13 | 2.29 | 2.49 | 2.45 |
| % Growth | -7% | -8% | 1.6% | – |
| EPS Diluted | 2.13 | 2.29 | 2.49 | 2.45 |
| Weighted Avg Shares Out | 11 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 11 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | €0 | €1 | €0 | €0 |
| Interest Expense | €29 | €27 | €21 | €20 |
| Depreciation & Amortization | €82 | €80 | €78 | €75 |
| EBITDA | €145 | €145 | €142 | €132 |
| % Margin | 18% | 19.6% | 19.5% | 19.1% |